|
平成31年・令和元年の東京都保菌者検索事業実施結果が確定いたしましたので、下記の通りお知らせします。
食品監視課食中毒調査担当
1 腸管出血性大腸菌の発生状況累計グラフ
（1）散発患者発生動向調査
| |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
| O157VT1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| O157VT2 |
1 |
0 |
0 |
0 |
1 |
1 |
0 |
1 |
1 |
1 |
0 |
0 |
1 |
1 |
1 |
1 |
6 |
4 |
| O157VT1,2 |
1 |
0 |
0 |
0 |
6 |
1 |
0 |
0 |
0 |
1 |
0 |
0 |
1 |
1 |
1 |
2 |
1 |
3 |
| その他 |
2 |
0 |
2 |
0 |
0 |
0 |
0 |
1 |
2 |
1 |
0 |
0 |
2 |
1 |
2 |
5 |
3 |
2 |
| 累計 |
4 |
4 |
6 |
6 |
13 |
15 |
15 |
17 |
20 |
23 |
23 |
23 |
27 |
30 |
34 |
42 |
52 |
61 |
| |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
| O157VT1 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| O157VT2 |
2 |
1 |
1 |
1 |
1 |
3 |
3 |
3 |
1 |
1 |
4 |
1 |
1 |
1 |
0 |
1 |
1 |
2 |
| O157VT1,2 |
8 |
2 |
9 |
4 |
4 |
11 |
7 |
22 |
5 |
3 |
0 |
2 |
1 |
3 |
0 |
1 |
0 |
0 |
| その他 |
5 |
3 |
5 |
2 |
4 |
3 |
2 |
3 |
2 |
3 |
0 |
1 |
1 |
0 |
4 |
2 |
1 |
0 |
| 累計 |
76 |
82 |
98 |
105 |
114 |
131 |
143 |
172 |
180 |
187 |
191 |
195 |
198 |
202 |
206 |
210 |
212 |
214 |
（２）無症状病原体保有者調査
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| O157VT1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
| O157VT2 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
2 |
0 |
0 |
| O157VT1,2 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
1 |
| その他 |
3 |
2 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
2 |
0 |
2 |
1 |
3 |
| 累計 |
4 |
6 |
6 |
6 |
6 |
6 |
6 |
6 |
6 |
6 |
6 |
6 |
8 |
10 |
11 |
15 |
18 |
23 |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| O157VT1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| O157VT2 |
1 |
1 |
0 |
0 |
1 |
0 |
2 |
1 |
0 |
1 |
0 |
1 |
0 |
2 |
0 |
0 |
0 |
0 |
| O157VT1,2 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| その他 |
1 |
1 |
1 |
3 |
2 |
0 |
2 |
1 |
0 |
3 |
4 |
0 |
0 |
1 |
1 |
1 |
0 |
0 |
| 累計 |
25 |
27 |
28 |
31 |
34 |
34 |
38 |
40 |
40 |
45 |
49 |
50 |
50 |
53 |
54 |
55 |
55 |
55 |
2 サルモネラの発生状況累計グラフ
（1）散発患者発生動向調査
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| O4 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
1 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
| O7 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
0 |
0 |
1 |
0 |
| O9 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| その他 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
| 累計 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
2 |
4 |
4 |
4 |
4 |
6 |
7 |
8 |
9 |
9 |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| O4 |
0 |
2 |
0 |
0 |
12 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
| O7 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| O9 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| その他 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
1 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| 累計 |
9 |
11 |
12 |
12 |
24 |
24 |
25 |
27 |
28 |
28 |
28 |
28 |
28 |
28 |
29 |
29 |
29 |
29 |
（２）無症状病原体保有者調査
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| O4 |
0 |
1 |
1 |
2 |
1 |
0 |
2 |
4 |
0 |
1 |
7 |
0 |
1 |
4 |
3 |
7 |
5 |
4 |
| O7 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
1 |
0 |
0 |
2 |
0 |
1 |
0 |
1 |
| O9 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
| その他 |
0 |
0 |
0 |
0 |
2 |
1 |
1 |
1 |
0 |
1 |
2 |
1 |
0 |
0 |
0 |
0 |
1 |
1 |
| 累計 |
0 |
2 |
3 |
5 |
8 |
9 |
12 |
17 |
17 |
20 |
29 |
30 |
31 |
37 |
40 |
48 |
54 |
61 |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| O4 |
2 |
5 |
1 |
0 |
1 |
0 |
4 |
2 |
0 |
1 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
| O7 |
0 |
3 |
0 |
1 |
3 |
1 |
3 |
2 |
1 |
1 |
0 |
0 |
1 |
2 |
0 |
0 |
0 |
1 |
| O9 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| その他 |
1 |
1 |
0 |
2 |
1 |
1 |
2 |
1 |
0 |
1 |
1 |
0 |
0 |
0 |
1 |
0 |
1 |
0 |
| 累計 |
65 |
74 |
75 |
78 |
83 |
85 |
94 |
99 |
100 |
103 |
104 |
104 |
105 |
107 |
109 |
109 |
110 |
111 |
|
